Re: Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer

被引：14
|
作者：
Drake, Charles G. [1 ]
机构：
[1] Johns Hopkins Univ, Dept Oncol, Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 18期
关键词：
HOMEOSTATIC PROLIFERATION; CELLS; REJECTION; MELANOMA;
D O I：
10.1093/jnci/djs340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1422 / 1422
页数：1
相关论文
共 50 条
  • [41] Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it
    Wang, Yuanyuan
    Chen, Jiyuan
    Wu, Zhengjie
    Ding, Weihong
    Gao, Shen
    Gao, Yuan
    Xu, Chuanliang
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 239 - 261
  • [42] Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
    Lin, H-M
    Castillo, L.
    Mahon, K. L.
    Chiam, K.
    Lee, B. Y.
    Nguyen, Q.
    Boyer, M. J.
    Stockler, M. R.
    Pavlakis, N.
    Marx, G.
    Mallesara, G.
    Gurney, H.
    Clark, S. J.
    Swarbrick, A.
    Daly, R. J.
    Horvath, L. G.
    BRITISH JOURNAL OF CANCER, 2014, 110 (10) : 2462 - 2471
  • [43] A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)
    Vibishan, B.
    Harshavardhan, B. V.
    Dey, Sutirth
    JOURNAL OF THEORETICAL BIOLOGY, 2024, 587
  • [44] A Phase II Trial of Temsirolimus in Men With Castration-Resistant Metastatic Prostate Cancer
    Armstrong, Andrew J.
    Shen, Tong
    Halabi, Susan
    Kemeny, Gabor
    Bitting, Rhonda L.
    Kartcheske, Patricia
    Embree, Elizabeth
    Morris, Karla
    Winters, Carolyn
    Jaffe, Tracy
    Fleming, Mark
    George, Daniel J.
    CLINICAL GENITOURINARY CANCER, 2013, 11 (04) : 397 - 406
  • [45] Raman spectroscopy, a potential tool in diagnosis and prognosis of castration-resistant prostate cancer
    Wang, Lei
    He, Dalin
    Zeng, Jin
    Guan, Zhenfeng
    Dang, Qiang
    Wang, Xinyang
    Wang, Jun
    Huang, Liqing
    Cao, Peilong
    Zhang, Guanjun
    Hsieh, JerTong
    Fan, Jinhai
    JOURNAL OF BIOMEDICAL OPTICS, 2013, 18 (08)
  • [46] Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer
    Sainio, Miika
    Visakorpi, Tapio
    Tolonen, Teemu
    Ilvesaro, Joanna
    Bova, G. Steven
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (06) : 848 - 856
  • [47] Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
    Lin, Hui-Ming
    Mahon, Kate L.
    Spielman, Calan
    Gurney, Howard
    Mallesara, Girish
    Stockler, Martin R.
    Bastick, Patricia
    Briscoe, Karen
    Marx, Gavin
    Swarbrick, Alexander
    Horvath, Lisa G.
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : 1002 - 1011
  • [48] Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer
    Hussain, A.
    DiPaola, R. S.
    Baron, A. D.
    Higano, C. S.
    Tchekmedyian, N. S.
    Johri, A. R.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 492 - 497
  • [49] Targeting Melatonin to Mitochondria Mitigates Castration-Resistant Prostate Cancer by Inducing Pyroptosis
    Chen, Xiaohui
    Kadier, Mairehaba
    Shi, Mengting
    Li, Kefeng
    Chen, Hongtao
    Xia, Yongzhen
    Wang, Qiaohua
    Li, Rongna
    Long, Yili
    Qin, Jingbo
    Wang, Hao
    Jiang, Guanmin
    SMALL, 2025,
  • [50] Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer
    Giridhar, Karthik V.
    Sanhueza, Cristobal
    Hillman, David W.
    Alkhateeb, Hassan
    Carlson, Rachel
    Tan, Winston
    Costello, Brian A.
    Quevedo, Fernando
    Pagliaro, Lance
    Kohli, Manish
    PROSTATE CANCER AND PROSTATIC DISEASES, 2018, 21 (03) : 431 - 437
12345